The Food and Drug Administration approves CAR T-Cell therapy Carvykti® as a second-line treatment and the CAR T-Cell therapy Abecma® as a third-line treatment for adult patients with multiple myeloma.
Read Press ReleaseThe Portland, Maine-Based Ownership and Management Firm Fathom Companies Opened the Hotel in June 2021
Read Press ReleaseMichael’s inclusion in Barron’s Top 1,200 Financial Advisors highlights his dedication to his clientele, his nearly three decades of experience in the field, and his commitment to making an impact in the comprehensive wealth management industry.
Read Press ReleaseNew SaaS Technology Introduces Patient-Centered Self-Sovereign Identity That Allows Decentralization for De-Identified Data With Secure Data Storage and Exchange With Optimal Security, Integrity, Transparency and Interoperability
Read Press ReleaseThis additional funding comes at the heels of Selux announcing their third FDA 510(k) clearance on their direct from Positive Blood Culture Separator, making them the only single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies.
Read Press Release